Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

600521

Clasificación en acciones #4328
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Precio por acción
$2.43
Capitalización bursátil
$3.64B
Cambio (1 día)
0.30%
Cambio (1 año)
-9.55%
País
CN
Comercio Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

Categoría

Healthcare
Ganancias de Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Ganancias en Jun 2026 TTM: $116.37M
Secondo gli ultimi rapporti finanziari di Zhejiang Huahai Pharmaceutical Co., Ltd., gli utili attuali della società sono $116.37M. Nel 2023, la società ha registrato un utile di $155.44M, una disminución en comparación con agli utili del 2022, che erano di $218.75M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Zhejiang Huahai Pharmaceutical Co., Ltd. desde 2000 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $116.37M -41.96%
2024 $200.52M 29.00%
2023 $155.44M -28.94%
2022 $218.75M 76.68%
2021 $123.81M -33.45%
2020 $186.04M 70.26%
2019 $109.27M 378.00%
2018 $22.86M -80.91%
2017 $119.77M 46.64%
2016 $81.68M 1.26%
2015 $80.66M 59.65%
2014 $50.52M -25.67%
2013 $67.97M 5.47%
2012 $64.44M 48.73%
2011 $43.33M 123.78%
2010 $19.36M -32.37%
2009 $28.63M 16.51%
2008 $24.57M -5.07%
2007 $25.88M 35.84%
2006 $19.05M -12.70%
2005 $21.83M 10.70%
2004 $19.72M 36.00%
2003 $14.50M 63.58%
2002 $8.86M 36.52%
2001 $6.49M 2.99%
2000 $6.30M 0.00%
Ganancias de empresas similares o competidoras